ProfileGDS4718 / 203118_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 96% 96% 86% 97% 96% 92% 89% 96% 96% 96% 96% 97% 95% 91% 92% 94% 95% 90% 95% 87% 96% 96% 96% 97% 96% 93% 96% 91% 97% 90% 92% 89% 96% 96% 90% 90% 90% 96% 97% 85% 96% 94% 91% 90% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]10.831996
GSM549102patient 115, normal, homogenized [OPG study]10.704196
GSM549104patient 119, normal, homogenized [OPG study]8.6008686
GSM549108patient 138, normal, homogenized [OPG study]10.828497
GSM549119patient 077, normal, homogenized [OPG study]10.552396
GSM549133patient 032, cancer, homogenized [OPG study]9.5842692
GSM549139patient 042, cancer, homogenized [OPG study]8.9593389
GSM549099patient 107, normal, homogenized [OPG study]10.623196
GSM549109patient 139, normal, homogenized [OPG study]10.710296
GSM549110patient 046, normal, homogenized [OPG study]10.793596
GSM549114patient 063, normal, homogenized [OPG study]10.678496
GSM549122patient 082, normal, homogenized [OPG study]10.842897
GSM549134patient 033, cancer, homogenized [OPG study]10.138595
GSM549136patient 036, cancer, homogenized [OPG study]9.4133691
GSM549140patient 044, cancer, homogenized [OPG study]9.557792
GSM549111patient 047, normal, homogenized [OPG study]10.232394
GSM549113patient 057, normal, homogenized [OPG study]10.459795
GSM549132patient 031, cancer, homogenized [OPG study]9.2052390
GSM549137patient 038, cancer, homogenized [OPG study]10.092595
GSM549142patient 047, cancer, homogenized [OPG study]8.3922487
GSM549100patient 110, normal, homogenized [OPG study]10.711396
GSM549107patient 135, normal, homogenized [OPG study]10.72196
GSM549115patient 068, normal, homogenized [OPG study]10.963996
GSM549116patient 072, normal, homogenized [OPG study]10.841497
GSM549120patient 078, normal, homogenized [OPG study]10.620896
GSM549131patient 030, cancer, homogenized [OPG study]9.7491193
GSM549118patient 074, normal, homogenized [OPG study]10.590696
GSM549129patient 027, cancer, homogenized [OPG study]9.1735491
GSM549123patient 088, normal, homogenized [OPG study]10.874597
GSM549124patient 006, cancer, homogenized [OPG study]9.1037590
GSM549126patient 015, cancer, homogenized [OPG study]9.5104492
GSM549128patient 025, cancer, homogenized [OPG study]9.0210489
GSM549103patient 117, normal, homogenized [OPG study]10.55496
GSM549117patient 073, normal, homogenized [OPG study]10.782296
GSM549138patient 041, cancer, homogenized [OPG study]9.2806990
GSM549141patient 045, cancer, homogenized [OPG study]9.2727990
GSM549130patient 028, cancer, homogenized [OPG study]9.1446490
GSM549101patient 111, normal, homogenized [OPG study]10.395596
GSM549105patient 128, normal, homogenized [OPG study]10.759197
GSM549106patient 134, normal, homogenized [OPG study]8.5773885
GSM549112patient 048, normal, homogenized [OPG study]10.644696
GSM549125patient 011, cancer, homogenized [OPG study]9.8461194
GSM549127patient 024, cancer, homogenized [OPG study]9.3605691
GSM549135patient 035, cancer, homogenized [OPG study]9.1921990